Background: Botulinum toxin represents a novel therapeutic option for idiopathic palmar hyperhidrosis. However, so far there is no consensus on the way to administer botulinum toxin in this indication. Moreover, its use is limited by severe pain during the injections, especially with subepidermal injections close to ‘free nerve endings’. Objectives: To analyze the effectiveness and tolerability of intracutaneous injections of botulinum toxin after nerve blocks and to review the techniques of injections and the results reported by other groups. Methods: Twenty-three adult patients with refractory palmar hyperhidrosis were treated with intracutaneous injections of botulinum toxin after ulnar and median nerve blocks. Patients were followed up on a monthly basis. Results: In all patients botulinum toxin abolished sweating in the injected areas within 1 week. Anhidrosis lasted for 4–13 months. The intensity of pain was rated as absent (n = 13), mild (n = 8) or moderate (n = 2). Other side effects included hematoma (n = 2) and pain consecutive to nerve block (n = 1). Discussion: Intracutaneous injections of botulinum toxin after median and ulnar nerve block represent an effective and mildly painful technique to treat palmar hyperhidrosis and may be as safe as subepidermal injections.

Keywords:
Botulinum toxin, Palmar hyperhidrosis, Nerve block, Muscle weakness, Intracutaneous injection
1.
Quinn AC, Edwards RE, Newman PJ, Fawcett WJ: Complications of endoscopic sympathectomy. Br Med J 1993;306:1752.
2.
Claes G, Drott C: Hyperhidrosis. Lancet 1994;343:247–248.
3.
Odderson R: Hyperhidrosis treated by botulinum A exotoxin. Dermatol Surg 1998;24:1237–1241.
4.
Böni R, Kreyden OP, Burg G: Revival of the use of botulinum toxin: Application in dermatology. Dermatology 2000;200:287–291.
5.
Heckmann M, Ceballos-Baumann O, Plewig G: Botulinum toxin for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;344:488–493.
6.
Münchau A, Bhatia KP: Uses of botulinum toxin injection in medicine today. Br Med J 2000;320:161–165.
7.
Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff E: Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol 1997;136:548–552.
8.
Shelley WB, Talanin NY, Shelley ED: Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol 1998;38:227–229.
9.
Holmes S, Mann C: Botulinum toxin in the treatment of palmar hyperhidrosis. J Am Acad Dermatol 1998;39:1040–1041.
10.
Heckmann M, Scaller M, Plewig G, Ceballos-Baumann A: Optimizing botulinum toxin therapy for hyperhidrosis. Br J Dermatol 1998;138:553–554.
11.
Naumann M, Hoffman U, Bergmann I, Hamm H, Toyka KV, Reiners K: Focal hyperhidrosis. Effective treatment with intracutaneous botulinum toxin. Arch Dermatol 1998;134:301–304.
12.
Naumann M, Bergmann I, Hofmann U, Hamm H, Reiners K: Botulinum toxin for focal hyperhidrosis: Technical considerations and improvements in application. Br J Dermatol 1998;139:1123–1124.
13.
Zaiac M, Weiss E, Elgart G: Botulinum toxin therapy for palmar hyperhidrosis with ADG needle. Dermatol Surg 2000;26:230.
14.
Solomon BA, Hayman R: Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol 2000;42:1026–1029.
15.
Naver H, Swartling C, Aquilonius SM: Palmar and axillary hyperhidrosis treated with botulinum toxin: One year clinical follow-up. Eur J Neurol 2000;7:55–62.
16.
Odderson IR: Hyperhidrosis treated with botulinum A exotoxin. Dermatol Surg 1998;24:1237–1241.
17.
Walton RL, Chick LR, Petry J, Borah G: Hand injuries: General principles; in Jurkiewicz MJ, Krizek TJ, Mathes SJ, Ariyan S (eds): Plastic Surgery. St Louis, Mosby, 1990, pp 605–643.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.